Tech Company Financing Transactions
BioStack Platforms Funding Round
Peak XV Partners participated in a $9.5 million Seed capital raise for BioStack Platforms. The round closed on 10/22/2026.
Transaction Overview
Company Name
Announced On
10/22/2026
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Seed
Investors
Peak XV Partners (Lead Investor)
Proceeds Purpose
The newly raised capital will be used to expand the engineering and data science team, scale clinical data partnerships with global hospital networks, and further develop its secure, privacy-compliant data platform infrastructure.
Company Information
Company Status
Private & Independent
Industry
Infrastructure
Mailing Address
Undisclosed
San Francisco, CA 94102
US
San Francisco, CA 94102
US
Phone
Undisclosed
Website
Email Address
Overview
BioStack stems from the visionary concept of bridging biological insight with cutting-edge computational technology--a symbolic "stack" of layers where clinical data, molecular biology, and AI converge. Inspired by the Biostack experiments conducted during the Apollo missions, which studied the effects of cosmic radiation on living organisms, the name encapsulates a spirit of exploration, precision, and boundary-pushing science. Just as those experiments laid the groundwork for understanding the biological challenges of space travel, BioStack represents a modern quest to decode life's complexities in the age of AI.
Management Team
Browse more venture capital transactions:
Prev: 10/22/2026: Watchtower Labs venture capital transaction
Next: 10/22/2026: Cuttable Operations venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








